Selected References

Adverse drug reactions in the United States, Medicine in the Public Interest Inc., Washington, DC, 1974.

Albin H Begaud B Boisseau A Dangoumau J : Validation des publications de'effets indesirables par une methode d'imputabilite Therapie 1980; 35:571–576.

Auriche M : Approache Bayesienne de L'imputabilite des Phenomenes Undesirables aux Medicaments. Therapie, 1985; 40:301–306.

Ausman RK Karch FE Kramer MS Jones JK Feinstein AR : Use of algorithms for assessing possible adverse drug reactions. Summary of talk by JK Jones. Communication at Standardizing Methods of Assessing Causality of Adverse Drug Reactions Meeting, Morges, June 14–18, 1981.

Australian Drug Evaluation Committee: Report of suspected adverse drug reactions, No 4, pv., Australian Government Publishing Service, Canberra, 1978.

Begaud B Haramburu F Pere JC Dangoumau J : Les criteres d'imputabilite confrontes a la pratique: A propose de 1000 observations Therapie 1982; 37:415–420.

Begaud B Boisseau A Albin H Dangoumau J : Comparison de quatre methods d'imputabilite des effects indesirables des medicaments Therapie 1981; 36:65–70.

Begaud B Boisseau A Albin H Dangoumau J : Imputabilite des effects indesirables des medicaments: Etude de 194 observations. Therapie 1978, 33:383.

Begaud B , Standardized assessment of adverse drug reactions: The method used in France Drug Inf J 1984; 18 (3/4):275–282.

Begaud B Pere JC Dangoumau J : Mise en oeuvre d'un critere: La bibliographie Therapie 1981; 6:233–236.

Bennett BS Lipman AG : Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions Am J Hosp Pharm 1977; 34: 931–936.

Benzecri JP : L'Analyse des Donnees, vol 2, L'Analyse de Correspondences. Paris, Dunod, 1973.

Berde B : The responsibility of the pharmaceutical industry, in Turner P (ed): Clinical Pharmacology and Therapeutics, Proceedings of the First World Conference on Clinical Pharmacology and Therapeutics. London, MacMillan Publishers, 1980, pp 572–576.

Berger JP Haller E Blanc E Brooke EM Schelling JL : Quelques facteurs intervenant dans les reactions adverses medicamenteuses Schweiz Med Wochenshr 1975; 105:1706.

Berneker GC Venulet J : About the problem, in Venulet J Berneker GC Ciucci AG (eds): Assessing Causes of Adverse Drug Reactions. London, Academic Press, 1982, pp 1–5.

Blanc S Leuenberger P Berger JP Brooke EM Schelling JL : Judgments of trained observers on adverse drug reactions Clin Pharmacol Ther 1979; 25:439–498.

Boisseau A Begaud B Albin H Dangoumau J : Reevaluation du diagnostic d'effet indesirable des medicaments avec un recul de six mois Therapie 1980; 35:577–580.

Busto U Naranjo CA Sellers EM : Comparisons of two recently published algorithms to assess the probability of adverse drug reactions, Abstracted, Clin Pharmacol Ther 1981; 29:236.

Busto U Naranjo CA Sellers EM : Comparison of two recently published algorithms for assessing the probability of adverse drug reactions Br J Clin Pharm 1982; 13:233–227.

Castle WM : Assessment of Causality in Industrial Settings Drug Inf J 1984; 18(3/4):297–302.

Dally S : Toxicologie et epidemiologic, in Masson (ed): Toxicovigilance. Paris, Coll Med Legale et Toxicol, pp 323–343.

Dangoumau J Begaud B : Interactions medicamenteuses et pharmacovigilance — Communication Symposium Droit et Pharmacie. Interactions medicamenteuses, co-prescriptions et associations a doses fixes. Paris, March 9–10, 1981.

Dangoumau J Evreux JC Jouglard J : Methode d'imputabilite des effects adverses des medicaments Therapie 1978; 33:373–381.

Dangoumau J Begaud B Boisseau A Albin H : Methods d'identification et d'imputabilite des effects indesirables des medicaments Therapie 1980; 35:287.

Dangoumau J Begaud A Boisseau A Albin H : Les difficultes du diagnostic des effects indesirables des medicaments Bordeax Med 1980; 13:283.

Dangoumau J Begaud A Boisseau A Albin H : Les difficultes du diagnostic des effects indesirables des medicaments Bordeaux Med 1980; 13:283.

Dufa BW : No-fault or strict liability scheme in action — Sweden, in Turner P (ed): Clinical Pharmacology and Therapeutics, Proceedings of the First World Conference on Clinical Pharmacology and Therapeutics. London, MacMillan Publishers, 1980, pp 565–571.

Dukes MNG : The uses of causality assessment. Drug Inf J, 1984; 18(3/4):227–232.

Emanueli A Sacchetti G : An algorithm for the classification of untoward events in large scale clinical trials Agents and Actions 1980; 73:318–322.

Emanueli A : A Simple Algorithm for Assessing Causality of Adverse Reactions. Drug Inf J, 1984; 18(3/4):303–306.

Emanueli A Sacchetti G : Post-marketing surveillance methodology as applied in a pharmaceutical medical department, in Aurich M Burke J Duchier J (eds): Drug Safety — Progress and Controversies. Paris, Pergamon Press, 1982, pp 265–273.

Eraker SA Sasse L : The serum digoxin test and digoxin toxicity: A Bayesian approach to decision making. Circulation, 1981; 64:409–42.

Evreux JCI Loupie E Ventre JJ : Essai d'evaluation de la responsabilite d'un effect adverse dans la survenue d'un deces Therapie 1981; 36: 249–254.

Feinstein AR : Clinical biostatistics XLVII. Scientific standards vs statistical associations and biologic logic in the analysis of causation Clin Pharmacol Ther 1979; 25:481–492.

Feinstein AR : Clinical biostatistics XXVIII. The biostatistical problems of pharmaceutical surveillance Clin Pharmacol Ther 1974; 16: 110.

Feinstein AR : Theoretical perspectives in causality assessment. Drug Inf J, 1984; 18(3/4): 219–226.

Feinstein AR Kramer MS : Clinical biostatistics LII. A primer on quantitative indexes of association Clin Pharmacol Ther 1980; 28:130–145.

Freilich WB : Legal perspectives in causality assessment Drug Inf J 1984; 18(3/4):211–218.

Hammond KR Joyce CRB : Psychological influences on human judgement, especially of adverse reactions, in Gross FH Inman WHW (eds): Drug Monitoring. London, Academic Press, 1977, pp 269–287.

Hasford J : Current concepts for assessing the drug — adverse event relationship and their problems, in Auriche M Burke J Duchier J (eds): Drug Safety — Progress and Controversies. Paris, Pergamon Press, 1982, p 257.

Hoigne R Streit CH Guleryuz D Stocker R Lepine A Stucki P : Fruherfassung and Bestimmung der Haufigkeit von Nebin-Wirkungen im Spital durch intensives (komprehensives) Soz Praventivmed 1980; 25:18–22.

Holland RR : Decision tables-their use for the presentation of clinical algorithms JAMA 1975; 233:455–457.

Hoskins JD Hurbert WT Selig JO : A questionnaire for the clinical assessment of veterinary adverse drug reactions Cornell Vet 1982; 72:1–14.

Hutchinson TA Leventhal JM Kramer MS Karch FE Lipman AG Feinstein AR : An algorithm for the operational assessment of adverse drug reactions, II Demonstration of reproducibility and validity JAMA 1979; 243:633–638.

Irey NS : Adverse drug reactions and death: A review of 827 cases JAMA 1976; 236:575.

Ivery NS : Diagnostic problems in drug-induced diseases, in Meyler L Peck HM (eds): Drug-Induced Diseases. Amsterdam, Excerpta Medica, 1972, vol IV: 1.

Irey NS : Tissue reactions to drugs Am J Pathol 1976; 82: 617–647.

Irey NS : Case report methods for assessing causality Drug Inf J 1984; 18(3/4):241–250.

James D Haller E Rosselet G Brooke EM Schelling JL : Frequence des precriptions de medicaments et de leurs effects indesirables dans un department de medicine Schweiz Med Wochenschr 1978; 108:1270–1277.

Jones JK : Adverse drug reactions in the community health setting: Approaches to recognizing, counseling, and reporting Fam Community Health 1982; 5:58–67.

Jones JK : Uses of drug-event assessment Drug Inf J 1984; 18(3/4):233–240.

Jones JK Dreis M Pearson KC : Summary of applications Drug Inf J 1984; 18(3/4):319–322.

Joubert PH Van Rijssen Jansen FW Venter JP : Drug side-effects assessed in “naturalistic” setting. S Afr Med J 1977: 52:34–36.

Joyce CRB : Identifying causes of disagreement in assessment of causality, in Venulet J Berneker GC Ciucci AG (eds): Assessing Causes of Adverse Drug Reactions. London, Academic Press, 1982, pp 95–103.

Kahneman D Stovic P Tvorsky A : Judgement Under Uncertainty: Heuristics and Biases. New York, Cambridge University Press, 1982.

Karch FE Lasagna L : Adverse drug reactions-a critical review JAMA 1975; 234:1236.

Karch FE Lasagna L : Evaluating adverse drug reactions. Adverse Drug React Bull 1976; 59.

Karch FE Lasagna L : Toward the operational identification of adverse drug reaction Clin Pharmacol Ther 1977; 21:247–254.

Karch FE Smith CL Kerzner B Mazullo JM Weintraub M Lasagna L : Adverse drug reactions — a matter of opinion Clin Pharmacol Ther 1976; 19:489–492.

Koch-Weser J : Validation of ADRs, in Gross FH Inman WHW (eds); Drug Monitoring. London, Academic Press, 1977, pp 79–89.

Koch-Weser J Greenblatt DJ : The ambiguity of adverse drug reactions, abstracted Clin Pharmacol Ther 1976; 19:110.

Koch-Weser J Sellers EM Zacest R : The ambiguity of adverse drug reactions Eur J Clin Pharmacol 1977; 11:75–78.

Koch-Weser J Sidel VW Sweet RH Kanarek P Eaton AE : Factors determining physician reporting of adverse reactions N Engl J Med 1969; 280:20–26.

Kramer MS : Assessing the causal relationship between drugs and their adverse effects. Drug Inf J 1981 (July/Dec); 147–151.

Kramer MS : Difficulties in assessing the adverse effects of drugs Br J Clin Pharm 1981; 11:108S–110S.

Kramer MS Leventhal JM Hutchinson TA Feinstein AR : An algorithm for the operational assessment of adverse drug reactions: I Background, description, and instructions for use JAMA 1979; 242:623–633.

Kramer MS Hutchinson TA Rudnick SA Leventhal JM Feinstein AR : Operational criteria for adverse drug reactions in evaluating suspected toxicity of a popular scabicide Clin Pharmacol Ther 1980; 27:149–292.

Kramer MS Hutchinson TA : The Yale algorithm. Drug Inf J 1984: 18(3/4):283–292.

Lagier G Vincens M Castot A Efthymiou ML : Diagnostic differential des leucopenies medicamenteuses Therapie 1982; 37:377–384.

Lagier G Evreux JC : L'efficacite en pharmacovigilance-2 L'outil informatique Therapie 1977; 32:151–159.

Lagier G Vincens M Castol A : “Imputabilite en pharmacovigilance: Principes de la methode appreciative ponderee et principales erreurs a eviter.” Therapie 1983; 38:303–318.

Lane DA : A probablist's view of causality assessment Drug Inf J 1984; 18(3/4):323–330.

Lasagna L : Bias in the elucidation of subject side effects Br J Clin Pharm 1981; 11:111S–1113S.

Leroy O Begaud B Dongoumau J Peytour P Salamon R : Etude comparative de quartre methodes d'imputabilite Therapie 1981; 36: 223–227.

Lesler H Fuding A : Pharmaceutical law in the United States, in Inman WHW (ed): Monitoring for Drug Safety. London, MacMillan Publishers, 1980, pp 511–529.

Leventhal JM Hutchinson TA Kramer MS Feinstein AR : An algorithm for the operational assessment of adverse drug reactions III. Results of tests among clinicians JAMA 1979; 242:1991–1994.

Maistrello I Grassi G Bertolino A Valerio P Pistollato G Soverini S : Unwanted symptoms in depressed patients treated with viloxazine: An algorithm for identification of illness-related symptoms Eur J Clin Pharmacol 1983; 24: 277–281.

Mashford ML : The Australian method of drugevent assessment Drug Inf J 1984; 18(3/4): 271–274.

Mayer I Meuth M Schumacher R : Intensive Drug Monitoring Medizinische, dissertation. Universitat Heidelberg, 1979.

McGeer EG : Neurotransmitter systems in aging and senile dementhia Prog Neuropsychopharmacol 1981; 5:435–445.

Meddelande fran Lakemeddsbiverknings Kommitten (Swedish). Meddelande No 20, 1974.

Miller RR : Interpretation of studies on adverse drug reactions Am J Hosp Pharm 1977; 34: 753–754.

Naranjo CA Fornazzari L Sellers EM : Clinical detection and assessment of drug-induced neurotoxicity Prog Neuropsychopharmacol 1981;5:427–434.

Naranjo CA Busto U Sellers EM Spino M Sandor P Ruiz I Roberts EA Janacek E Greenblatt DJ : Improved reliability using a rating scale to assess the probability of adverse drug reactions, abstracted. World Conference on Clinical Pharmacology & Therapeutics, London, 1980.

Naranjo CA Busto U Sellers EM Sandor P Ruiz I Roberts EA Janacek E Domecq C Greenblatt DJ : A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 1981; 30:239–245.

Naranjo CA Busto U Abel JG Sellers EM : Empiric delineation of the probability spectrum of adverse drug reactions, abstracted Clin Pharmacol Ther 1981; 29:267–268.

Naranjo CA Pontigo E Valdenegro C Gonzalez G Ruiz I Busto U : Furosemide-induced adverse reactions in cirrhosis of the liver Clin Pharmacol Ther 1979; 25:154–160.

Pere JL Begaud B Albin H Dangoumau J : Effects indesirables non decrit? — De L'observations aux donnees de la litterature Therapie 1981;36:237–240.

Petrie WM Levine J : The assessment of adverse drug reactions in clinical trials Int Pharmacopsychiatry 1978; 13:209–216.

Ruiz I Naranjo CA Campillo G : Influence de l'insuffisance renale sur la frequence des effects indesirables des medicaments Therapie 1977; 32:271–281.

Salamon R Peytour P : Recherche due poids des criteres dans un algorithme d'imputabilite Therapie 1981; 36:229–231.

Seidl LG Thornton GF Cluff LE : Epidemiological studies of adverse drug reactions Am J Public Health 1965; 55:1170.

Sellers EM : Adverse drug reactions: Uncommon or unrecognized? Clin Med Assoc J 1979; 120:1200–1201.

Shapiro S : Problems in the detection and quantification of adverse drug reactions Drug Inf J 1984; 18(3/4):251–254.

Siehr KG : Drug reactions and the law in the European Economic Community, in Inman WHW (ed): Monitoring for Drug Safety. London, MacMillan Publishers, 1980, pp 489–509.

Siehr KG : Regulatory and legal aspects, in Venulet GC Berneker AG Ciucci AG (eds): Assessing Causes of Adverse Drug Reactions. London, Academic Press, 1982, 129–141.

Sox HC : Probability theory in use of diagnostic tests Ann Intern Med 1986; 104:60–66.

Spitzer RL Fleiss JL Endicott J : Problems of classification: Reliability and validity, in Lipton MA DiMasco A Killam KF (eds): Psycho-pharmacology: A Generation of Progress. New York, Raven Press, 1978, pp 857–869.

Stephens M : Assessment of causality in industrial settings Drug Inf J 1984; 18(3/4):307–314.

Tallarida RJ Murray RB Eiben C : A scale for assessing the severity of diseases and adverse drug reactions Clin Pharmacol Ther 1979; 25: 381–390.

Turner W : The Food and Drug Administration Algorithm Drug Inf J 1984; 18(3/4):259–266.

Venning GR : Validity of anecdotal reports of suspected adverse drug reactions: The problem of false alarms Br Med J 1982; 284:249–252.

Venulet J : Methods of monitoring adverse reactions to drugs, in Jucker E (ed): Progress in Drug Research. Basel, Birkhauser Verlag, 1972, vol 21, pp 233–292.

Venulet J : Aspects of standardization as applied to the assessment of drug-event association Drug Inf J 1984; 18(3/4): 199–210.

Venulet J : The Ciba-Geigy approach to causality Drug Inf J 1984; 18(3/4):315–318.

Venulet J Blattner RR Von Bulow J Berneker GC : How good are articles on adverse drug reactions? Br Med J 1982; 284:252–254.

Venulet J : Monitoring adverse drug reactions — the problem of integration of heterogenous data Int J Clin Pharmacol Biopharm 1979; 17: 383–386.

Venulet J Ciucci AG : Assessment of the cause and effect relationship of suspected adverse drug reactions, in Auriche M Burke J Duchier J (eds): Drug Safety — Progress and Controversies. Paris, Pergamon Press, 1982, pp 83–91.

Venulet J Berneker GC Ciucci AG , (eds): Assessing Causes of Adverse Drug Reactions. London, Academic Press, 1982.

Venulet J Ciucci A Berneker GC : Standardized assessment of drug-adverse reaction associations — rationale and experience Int J Clin Pharmacol Ther Toxicol 1980; 18:381–388.

Weintraub M : The general clinical pharmacology ‘bias elimination’ method Drug Inf J 1984; 18(3/4):293–296.

Weber JCP : Storage and retrieval of data on adverse reactions to drugs. Communication at Standardizing Method of Assessing Causality of Adverse Drug Reactions Meeting, Morges, June 14–18, 1981, in Venulet J Berneker GC Ciucci AG (eds): Assessing Causes of Adverse Reactions. London, Academic Press, 1982.

WHO'S Report of suspect drug reaction, 1981.

Williams RN : Principles of no-fault or strict liability, in Turner P (ed): Clinical Pharmacology and Therapeutics, Proceedings of the First World Conference on Clinical Pharmacology and Therapeutics. London, MacMillan Publishers, 1980, pp 557–564.

Wilmers J : The law in relation to unforeseen adverse drug reactions in the United Kingdom, in Inman WHW (ed): Monitoring for Drug Safety. Lancaster, TP Press, 1980, pp 483–488.

Wiholm B-E. The Swedish drug-event assessment method. Drug Inf J 1984; 18(3/4):267–270.